Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection.
Kasia A SablikMarian C Clahsen-van GroningenDennis A HesselinkTeun van GelderMichiel G H BetjesPublished in: PloS one (2018)
A high Tac IPV per se does not predispose to the development of c-aABMR but is associated with inferior graft survival once c-aABMR is diagnosed.